Bristol-Myers, Others Appeal Revlimid MDL To 3rd. Circ.

By Aneeta Mathur-Ashton · October 26, 2026, 6:01 PM EDT

Bristol-Myers Squibb, Natco Pharma, AbbVie and other pharmaceutical companies have sought permission to file an interlocutory appeal for a sprawling antitrust multidistrict litigation over Celgene Corp.'s cancer drug Revlimid to the...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

HUMANA INC., et al v. CELGENE CORPORATION, et al

Case Number

2:19-cv-07532

Court

New Jersey

Nature of Suit

Anti-Trust

Date Filed

March 01, 2019

Case Title

UNITED HEALTHCARE SERVICES, INC. v. CELGENE CORPORATION

Case Number

2:20-cv-18531

Court

New Jersey

Nature of Suit

Anti-Trust

Date Filed

December 08, 2020